Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

Wolfgang Hiddemann, Anna Maria Barbui, Miguel A. Canales, Paul K. Cannell, Graham P. Collins, Jan Dürig, Roswitha Forstpointner, Michael Herold, Mark Hertzberg, Magdalena Klanova, John Radford, John F. Seymour, Kensei Tobinai, Judith Trotman, Alis Burciu, Günter Fingerle-rowson, Marcel Wolbers, Tina Nielsen, Robert E. Marcus

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science